Skip to content

First in Man Aer-O-Scope

A Single-center Study to Evaluate the Safety & Performance of the Aer-O-Scope for Traveling Through the Colon in Healthy Volunteers

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02102412
Enrollment
101
Registered
2014-04-02
Start date
2005-02-28
Completion date
2008-12-31
Last updated
2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening Colonoscopy for Low Risk Subjects

Keywords

crc, colonoscopy, colon cancer

Brief summary

A single center study intended to evaluate the Aer-O-Scope Colonoscope System.

Detailed description

A clinical study in Zagreb Croatia, intended to evaluate the Aer-O-Scope Colonoscope System. The study includes 120 subjects and has the following endpoints: Evaluation of the Aer-O-Scope advancement, imaging and retraction throughout the Colon. Safety: No occurrence of any device related major adverse event (for details see section 9.5) Efficacy: 1. Advancement of device towards the ceacum and retraction 2. Visualization of the colon mucosa by the traveling imaging device 3. Procedure duration 4. Handling and operation (assessment by operator)

Interventions

BIOLOGICALscreening colonoscopy

performance of a colonoscopy with the experimental device followed by complete conventional colonoscopy

Sponsors

GI View Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers between 18 and 65 years of age. * Sign informed consent.

Exclusion criteria

* Subjects with any known GI related symptoms complaints or GI diseases. * Subjects with cancer or other life threatening diseases or conditions. * Pregnant women. * Subjects who underwent any abdominal surgery. * Morbid Obesity (BMI \> 40). * Drug abuse or alcoholism. * Bed-ridden subject. * Inadequate communication with the subject. * Subjects under custodial care. * Participation in any clinical study within the last 30 days. * Subjects with known cardiovascular and pulmonary diseases.

Design outcomes

Primary

MeasureTime frameDescription
Ability to traverse the colon using the aer-o-scopeunder 60 minutesa propulsion system using low pressure co2 gas and balloons is used to propel the system through the colon

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026